Solid Organ Transplant Recipients With SARS-CoV-2 French Registry
- Conditions
- SARS-CoV-2
- Registration Number
- NCT04360707
- Lead Sponsor
- University Hospital, Strasbourg, France
- Brief Summary
Patients with comorbid condition are known to be at high risk of severe forms of Covid-19. It is highly probable that immunocompromised patients like solid organ transplant (SOT) recipients are also at risk of severe forms of Covid-19. For this purpose, The investigators conducted a nationwide multicentric and multiorgan Registry to collect data about all French SOT recipients who develop a SARS-CoV-2 infection. The aim is to describe the clinical, biological and virological characteristics of these patients and to give information about evolution and prognosis of these particular population
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
- All Solid Organ Transplant recipients with a functioning graft and a high suspicion or a confirmed SARS-CoV-2 infection
- Adult and pediatric
Exclusion Criteria
- There are no exclusion criteria, except for the patient's explicit refusal to participate
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical Presentation and Incidence of Covid-19 Infection in Different Cohorts of Solid Organ Transplant Patients From 1st March 2020 to 1st March 2021
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Service de Néphrologie et Transplantation
🇫🇷Strasbourg, France